In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Surgical Outcomes from Transsphenoidal Resection of Nonfunctioning Pituitary Adenomas: A Single-Center Experience of Over 400 Patients

    Final Number:
    1593

    Authors:
    Joshua W. Lucas MD; Michael Lin-Brande; John D. Carmichael MD; Daniel Kelley; Martin H. Weiss MD; Gabriel Zada MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: The prevalence of nonfunctioning pituitary adenoma (NFPA) is estimated at 22.2 per 100,000 people. Many reports have characterized the diagnosis and treatment of NFPAs, yet few large-scale studies have evaluated outcomes of surgical resection of these lesions.

    Methods: We performed a single-center retrospective review of 411 patients who underwent transsphenoidal surgery for NFPA from 1994-2014, with minimum follow-up time of 3 months (mean 51 months).

    Results: Our series consisted of 220 men (54%) and 191 women (46%) with mean age of 57 years. The most prevalent preoperative symptoms were vision loss (226 patients, 55.0%) and headache (153 patients, 37.2%). Mean tumor diameter was 25.9cm. 234 patients (57%) demonstrated cavernous sinus invasion on MRI. Gross total resection was achieved in 283 patients (68.8%). Intraoperative CSF leakage was identified in 212 cases (51.5%). Median hospital stay was 2 days. There were no perioperative deaths and no carotid artery injuries. Complications included diabetes insipidus (24 patients, 5.8%), new hypopituitarism (18 patients, 4.5%), postoperative CSF rhinorrhea (11 patients, 2.7%), cranial nerve paresis (8 patients, 1.9%), hematoma (8 patients, 1.9%), meningitis (6 patients, 1.5%), worsened vision (4 patients, 1%), and hydrocephalus (4 patients, 1%). Rates of early readmission and reoperation were 7.1% and 5.1%, respectively. Recurrence occurred in 25 patients (6.1%) with a mean time to recurrence of 67.6 months. Progression was seen in 37 patients (9.0%) with average time to progression of 41.8 months. At latest follow-up, 222 patients (54.0%) had no evidence of disease, 163 patients (39.6%) had stable residual disease, and 26 patients (6.3%) had disease progression.

    Conclusions: Transsphenoidal surgery is a safe and effective first-line therapy for NFPAs, with low rates of surgical complications. In a large series of patients with mean follow-up time of over 4 years, over 93% of patients had stable or no disease at latest postoperative follow-up.

    Patient Care: This research is one of the few large-scale studies reporting long-term surgical outcome data for the resection of NFPAs. This will improve discussion with patients regarding major complications and rates of gross total resection, residual disease, and progression.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the major complications of transsphenoidal resection of NFPAs, 2) Describe the rates of gross total resection of NFPAs using a transsphenoidal approach, 3) Understand the safety and efficacy of the transsphenoidal approach for resection of NFPAs.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy